These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12722341)

  • 61. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB; Bajzar L
    J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acquired alpha-2 anti-plasmin deficiency secondary to amyloidosis.
    Clyne LP; Caldwell AB
    Thromb Haemost; 1987 Aug; 58(2):797. PubMed ID: 3672434
    [No Abstract]   [Full Text] [Related]  

  • 63. Plasminogen/plasmin regulates alpha-enolase expression through the MEK/ERK pathway.
    Sousa LP; Silva BM; Brasil BS; Nogueira SV; Ferreira PC; Kroon EG; Kato K; Bonjardim CA
    Biochem Biophys Res Commun; 2005 Dec; 337(4):1065-71. PubMed ID: 16225843
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of black-pigmented bacteria on the plasminogen-plasmin system in human pulp and osteoblastic cells.
    Yang SF; Hsieh YS; Huang FM; Yang LC; Chang YC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):621-5. PubMed ID: 12738955
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structural consideration of the formation of the activation complex between the staphylokinase-like streptococcal plasminogen activator PadA and bovine plasminogen.
    Ward PN; Abu-Median AB; Leigh JA
    J Mol Biol; 2008 Sep; 381(3):734-47. PubMed ID: 18588895
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
    Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
    Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Contribution of proteases and plasmin-acquired activity in migration of Peptostreptococcus micros through a reconstituted basement membrane.
    Grenier D; Bouclin R
    Oral Microbiol Immunol; 2006 Oct; 21(5):319-25. PubMed ID: 16922932
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel variant causing α2 antiplasmin deficiency: case report and experience in a UK centre.
    Akay M; Zaidi A; Vaidya S; Sivapalaratnam S; Theodoulou A; Platton S; Hart D; Pasi J; Bowles L
    Br J Haematol; 2019 Oct; 187(2):e42-e44. PubMed ID: 31441040
    [No Abstract]   [Full Text] [Related]  

  • 69. [Congenital deficiency of alpha 2-antiplasmin in three sisters (author's transl)].
    Kamitsuji H; Yoshioka A; Takase T; Mikami S; Iida Y; Tsukada S; Fukui H
    Rinsho Ketsueki; 1981 Jul; 22(7):1160-7. PubMed ID: 7328770
    [No Abstract]   [Full Text] [Related]  

  • 70. [Alpha 2-plasmin inhibitor].
    Aoki N
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1339-50. PubMed ID: 1761916
    [No Abstract]   [Full Text] [Related]  

  • 71. [Analysis of alpha 2-plasmin inhibitor].
    Mimuro J; Aoki N
    Rinsho Byori; 1985 Feb; Spec No 61():97-105. PubMed ID: 2860263
    [No Abstract]   [Full Text] [Related]  

  • 72. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Congenital deficiency of alpha 2-plasmin inhibitor].
    Aoki N
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):999-1002. PubMed ID: 3270919
    [No Abstract]   [Full Text] [Related]  

  • 74. [Congenital plasmin inhibitor deficiencies: basic concepts and clinical applications].
    Nakahara M; Koyama T
    Rinsho Ketsueki; 2003 Mar; 44(3):149-58. PubMed ID: 12722341
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.